Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

The purpose of the study is to learn whether the study drug (capmatinib) helps to control lung cancer better compared to a single agent chemotherapy (docetaxel) and whether it is safe when given to patients suffering from a particular type of lung cancer. This type of cancer is called non-small …

epidermal growth factor receptor
measurable disease
systemic therapy
cancer chemotherapy
docetaxel
  • 0 views
  • 13 Jun, 2021
  • 43 locations
Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

therapy goal for ALS. The researchers propose an investigational therapy of ALS with oral administration of Olanzapine. The rationale for this study is based on the weight-increasing effect of

primary lateral sclerosis
riluzole
neurodegenerative disorders
atrophy
  • 40 views
  • 07 Nov, 2020
  • 1 location
Proton or Photon RT for Retroperitoneal Sarcomas

investigational therapy to use for further studies. "Investigational" means that the intervention is still being studied and that research doctors are trying to find out more about it. Retroperitoneal

  • 2 views
  • 25 Jan, 2021
  • 10 locations
Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

A Phase 2 study of nivolumab plus ipilimumab in previously treated classical Kaposi Sarcoma (CKS)

  • 0 views
  • 22 Jan, 2021
  • 1 location
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

cancer
allogeneic transplantation
  • 0 views
  • 02 Mar, 2021
  • 6 locations
Niraparib in Patients With Pancreatic Cancer

This research study is studying an investigational therapy as a possible treatment for pancreatic cancer. The drugs involved in this study are: -Niraparib

palb2
ct scan
folfirinox
corticosteroids
BRCA2
  • 61 views
  • 21 May, 2021
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease

/progressive/refractory CNS tumors): The first TAA-T dose will be infused any time >14 days after completing most recent course of conventional (non-investigational) therapy for their disease AND after

cancer
residual tumor
nervous
ependymoma
cns neoplasm
  • 4 views
  • 25 Jan, 2021
  • 1 location
Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection

Current management of COVID-19 (coronavirus) is mainly supportive, and respiratory failure from acute respiratory distress syndrome (ARDS) is the leading cause of mortality. Cytokines and chemokines are thought to play an important role in immunity and immunopathology during virus infections. Patients with severe COVID-19 have higher serum levels of pro-inflammatory …

  • 0 views
  • 02 Feb, 2021
  • 1 location
A Study of Melphalan BCNU Vitamin B12b Vitamin C and Stem Cell Infusion in People With Advanced Pancreatic Cancer and BRCA Mutations

The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on pancreatic cancer in patients who have an inherited, deleterious BRCA1 or BRCA2 genetic alteration. The investigational treatment will involve 2 cycles of a combination of intravenous melphalan, BCNU, low-dose I.V. ethanol, …

  • 0 views
  • 14 Jun, 2021
  • 1 location
Acalabrutinib Venetoclax and Obinutuzumab for Initial Therapy of CLL

This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab -- as a possible treatment for chronic lymphocytic leukemia (CLL). The drugs involved in this study are: Acalabrutinib Venetoclax Obinutuzmab

lymphocytosis
lymphadenopathy
corticosteroids
monoclonal antibodies
gilbert's syndrome
  • 156 views
  • 25 Jan, 2021
  • 3 locations